MSH|^~\&|ADM|ARH|||201910161531||ADT^A08|4080688|D|2.2|||AL|NE
EVN|A08|201910161531||||
PID|1|FHATVIG0010764||AB8113|EDMTEST^JARED1||19970827|M||||||||||AB000457/19|
PV1|1|P|AB.ER|||||||||||||||ER|||||||||||||||||||||ARH|||||201908271229|
PV2|||
OBX|1|ST|1010.1^WEIGHT^CPT4||52.000||||||F
OBX|2|CE|Ac00000700^Upper body washing support provided^ADM||8^Independent||||||F
OBX|3|CE|Ac00000900^Mouth care support provided^ADM||8^Independent||||||F
OBX|4|CE|Ac00001000^Grooming support provided^ADM||8^Independent||||||F
OBX|5|CE|Ac00001100^Toileting hygiene ability^ADM||8^Independent||||||F
OBX|6|CE|Ac00003700^Lower body washing support provided^ADM||8^Independent||||||F
OBX|7|CE|AcADLWAT00^Wash type performed^ADM||1^Full bed bath||||||F
OBX|8|CE|AcMOCAPE00^Mouth care performed^ADM||1^Oral suction||||||F
OBX|9|TX|AcMOUCAO00^Mouth care performed other^ADM||test||||||F
OBX|10|TX|AcPERSCC00^Personal care comments^ADM||test||||||F
OBX|11|CE|AcTOASST02^Toileting assistance^ADM||1^Unassisted||||||F
OBX|12|TX|AdACINNA01^Name of accompanying individuals^ADM||test||||||F
OBX|13|TX|AdACRTN00^Name of accompanying individuals^ADM||test||||||F
OBX|14|TX|AdEDADLO00^Other care activity comments^ADM||test||||||F
OBX|15|TX|AdMRPNAM00^MRP or physician name^ADM||test||||||F
OBX|16|TX|AdNEWBO330^Skin comments^ADM||test||||||F
OBX|17|TX|AdNOKIDA00^Next of kin/individual notified date^ADM||20191012||||||F
OBX|18|TX|AdNOKINA00^Name of next of kin/individual notified^ADM||test||||||F
OBX|19|TX|AdNOKINN00^Next of kin/individual notified^ADM||Y||||||F
OBX|20|TX|AdNOKITI00^Next of kin/individual notified time^ADM||1000||||||F
OBX|21|TX|AdOTPC0000^Other therapeutic pass comments^ADM||test||||||F
OBX|22|TX|AdOU000200^Code blue called time^ADM||1100||||||F
OBX|23|TX|AdPDDPT000^Pre-determined date for patient/family to contact unit^ADM||20191015||||||F
OBX|24|TX|AdPDTPT000^Pre-determined time for patient/family to contact unit^ADM||1000||||||F
OBX|25|CE|AdPU000000^Pass update^ADM||1^Call received||||||F
OBX|26|TX|AdPUC00000^Pass update comments^ADM||rdy||||||F
OBX|27|TX|AdPWVD0000^Pass with view to discharge^ADM||Y||||||F
OBX|28|TX|AdRCWP000^Reported concerns while on pass^ADM||est||||||F
OBX|29|CE|Ca00000100^Right radial pulse^ADM||1^Doppler||||||F
OBX|30|CE|Ca00000200^Right ulnar pulse^ADM||1^Doppler||||||F
OBX|31|CE|Ca00000400^Left radial pulse^ADM||1^Doppler||||||F
OBX|32|CE|Ca00000500^Left ulnar pulse^ADM||1^Doppler||||||F
OBX|33|CE|Ca00000700^Right dorsalis pedis pulse^ADM||1^Doppler||||||F
OBX|34|CE|Ca00000800^Right post tibial pulse^ADM||1^Doppler||||||F
OBX|35|CE|Ca00000900^Right popliteal pulse^ADM||1^Doppler||||||F
OBX|36|CE|Ca00001000^Left dorsalis pedis pulse^ADM||1^Doppler||||||F
OBX|37|CE|Ca00001100^Left post tibial pulse^ADM||1^Doppler||||||F
OBX|38|CE|Ca00001200^Left popliteal pulse^ADM||1^Doppler||||||F
OBX|39|CE|Ca00001300^Right femoral pulse^ADM||1^Doppler||||||F
OBX|40|CE|Ca00001400^Left femoral pulse^ADM||1^Doppler||||||F
OBX|41|TX|Ca00001800^Cardiovascular pre-hospital baseline^ADM||test||||||F
OBX|42|CE|Ca00001900^Cardiovascular assessment^ADM||1^Within defined parameters||||||F
OBX|43|TX|CaCAVASC00^Other cardiovascular comments^ADM||test||||||F
OBX|44|CE|CaCODE0000^Escalation of care^ADM||1^Code blue called||||||F
OBX|45|CE|CaCODE0002^Code blue call outcome^ADM||1^Stabilized||||||F
OBX|46|TX|CaCODE0004^Brief summary of deterioration^ADM||test||||||F
OBX|47|TX|CaCODE0100^Escalation of care other^ADM||test||||||F
OBX|48|TX|CaCODE0200^911 call time^ADM||0900||||||F
OBX|49|TX|CaCODE0300^Event comments^ADM||test||||||F
OBX|50|CE|CaCRFOLE01^Capillary refill left foot^ADM||1^Less than 3 seconds||||||F
OBX|51|CE|CaCRFORI01^Capillary refill right foot^ADM||1^Less than 3 seconds||||||F
OBX|52|CE|CaCRHALE00^Capillary refill left hand^ADM||1^Less than 3 seconds||||||F
OBX|53|CE|CaCRHARI00^Capillary refill right hand^ADM||1^Less than 3 seconds||||||F
OBX|54|TX|CaCY000000^Skin cyanosis other^ADM||test||||||F
OBX|55|CE|CaCYANOS00^Cyanosis^ADM||1^None||||||F
OBX|56|CE|CaEDEMA000^Edema^ADM||1^Not present||||||F
OBX|57|TX|CaTPSRS000^Circulation satisfactory^ADM||Y||||||F
OBX|58|TX|CaVTCOAG00^VTE prevention anticoagulant ordered^ADM||Y||||||F
OBX|59|CE|CaVTCOMP02^VTE prevention sequential compression device in use^ADM||1^None||||||F
OBX|60|CE|CaVTSTOC01^VTE prevention antiembolic stockings in use^ADM||1^None||||||F
OBX|61|TX|CmCOTRIA01^Compensatory strategies trialled details^ADM||test||||||F
OBX|62|CE|CmCTRIAL00^Compensatory strategies trialled^ADM||1^Reduced rate of intake||||||F
OBX|63|TX|CmCTRIAL01^Compensatory strategies trialled other^ADM||test||||||F
OBX|64|TX|CmMRP00000^Summary of information provided to MRP or physician^ADM||test||||||F
OBX|65|TX|CmMRPCDA01^MRP or physician communication date^ADM||20191011||||||F
OBX|66|CE|CmMRPCDE01^MRP or physician contact details^ADM||1^Contact made||||||F
OBX|67|CE|CmMRPCME01^MRP or physician communication method^ADM||1^In person||||||F
OBX|68|TX|CmMRPCOC01^MRP or physician communication outcome^ADM||test||||||F
OBX|69|TX|CmMRPCTI01^MRP or physician communication time^ADM||1325||||||F
OBX|70|CE|CmSL004601^Fluency of speech^ADM||1^Within functional limits||||||F
OBX|71|TX|CmSL004700^Fluency of speech other^ADM||test||||||F
OBX|72|CE|CoNOVECO00^Nonverbal communication^ADM||1^Not interacting||||||F
OBX|73|TX|CoNOVEOO00^Nonverbal communication other^ADM||test||||||F
OBX|74|TX|EdICCOUG00^Cough^ADM||Y||||||F
OBX|75|TX|EdICDIAR00^Diarrhea or vomiting^ADM||Y||||||F
OBX|76|TX|EdICFEVE00^Fever and rash^ADM||Y||||||F
OBX|77|TX|EdICIMMU00^Immuno-compromised^ADM||Y||||||F
OBX|78|TX|Gi00000600^Maintaining baseline stool pattern^ADM||Y||||||F
OBX|79|TX|Gi00001400^Gastrointestinal pre-hospital baseline^ADM||Test||||||F
OBX|80|CE|Gi00001500^Gastrointestinal assessment^ADM||1^Within defined parameters||||||F
OBX|81|TX|Gi00001600^Genitourinary pre-hospital baseline^ADM||test||||||F
OBX|82|CE|Gi00001700^Genitourinary assessment^ADM||1^Within defined parameters||||||F
OBX|83|TX|Gi00001800^Bladder scan comments^ADM||test||||||F
OBX|84|TX|GiABAPGE00^Abdominal general appearance^ADM||test||||||F
OBX|85|TX|GiABGIRT00^Abdomen abdominal girth^ADM||38.00||||||F
OBX|86|CE|GiABPALP02^Abdominal palpation^ADM||1^Soft||||||F
OBX|87|TX|GiABPAOT00^Abdominal palpation findings other^ADM||test||||||F
OBX|88|CE|GiABSHAP00^Abdominal shape^ADM||1^Flat||||||F
OBX|89|TX|GiABSHOT00^Abdominal shape other^ADM||test||||||F
OBX|90|CE|GiBM000000^Bowel movement method^ADM||1^Toilet||||||F
OBX|91|CE|GiBM000100^Bowel movement colour^ADM||2^Green~3^Brown||||||F
OBX|92|CE|GiBMAMT201^Bowel movement amount^ADM||1^Small (less than 120 mL)||||||F
OBX|93|TX|GiBMINCO00^Bowel movement incontinence^ADM||Y||||||F
OBX|94|TX|GiBMINTC01^Bowel movement level of intervention comments^ADM||test||||||F
OBX|95|CE|GiBMINTE01^Bowel movement level of intervention^ADM||1^Digital rectal check||||||F
OBX|96|TX|GiBMINTO00^Bowel movement level of intervention other^ADM||test||||||F
OBX|97|TX|GiBMMEOT00^Bowel movement method other^ADM||test||||||F
OBX|98|CE|GiBOFLAT00^Bowel flatus present^ADM||1^Absent||||||F
OBX|99|CE|GiBOWELLLQ^Bowel sounds lower left quadrant^ADM||1^Active||||||F
OBX|100|CE|GiBOWELLRQ^Bowel sounds lower right quadrant^ADM||1^Active||||||F
OBX|101|CE|GiBOWELULQ^Bowel sounds upper left quadrant^ADM||1^Active||||||F
OBX|102|CE|GiBOWELURQ^Bowel sounds upper right quadrant^ADM||1^Active||||||F
OBX|103|CE|GiBSACTI01^Bowel sounds active in all four quadrants^ADM||1^Yes||||||F
OBX|104|TX|GiBSST0001^Bristol Chart stool consistency^ADM||7||||||F
OBX|105|TX|GiCONSTI00^Patient experiencing constipation^ADM||Y||||||F
OBX|106|TX|GiDIARRH00^Patient experiencing diarrhea^ADM||Y||||||F
OBX|107|CE|GiEFT00500^Exudate description^ADM||1^Serous||||||F
OBX|108|TX|GiNAUSVO00^Patient experiencing nausea/vomiting^ADM||Y||||||F
OBX|109|TX|GiSKINNT00^Surrounding skin intact^ADM||Y||||||F
OBX|110|TX|Gu00000000^Genitalia/Perineum concerns^ADM||test||||||F
OBX|111|TX|GuAFBA0000^Arteriovenous fistula bruit audible^ADM||Y||||||F
OBX|112|CE|GuAFLOC000^Arteriovenous fistula location^ADM||1^Right arm||||||F
OBX|113|TX|GuAFTP0000^Arteriovenous fistula thrill palpable^ADM||Y||||||F
OBX|114|TX|GuBDINCO00^Bladder incontinence^ADM||Y||||||F
OBX|115|TX|GuBDSVA000^Bladder scan volume^ADM||520||||||F
OBX|116|TX|GuBDURSO00^Urinary retention signs and symptoms other^ADM||test||||||F
OBX|117|CE|GuBDURSS01^Urinary retention signs and symptoms^ADM||1^None||||||F
OBX|118|TX|GuBDUTIO00^Urinary tract infections signs and symptoms other^ADM||test||||||F
OBX|119|CE|GuBDUTIS00^Urinary tract infection signs and symptoms^ADM||1^None||||||F
OBX|120|CE|GuBDVM0002^Voiding method^ADM||1^Toilet||||||F
OBX|121|TX|GuBDVMO000^Voiding method other^ADM||test||||||F
OBX|122|CE|GuDI000100^Dialysis type^ADM||1^Hemodialysis||||||F
OBX|123|TX|GuPD000100^Dialysate 1 volume^ADM||1000||||||F
OBX|124|TX|GuPD000200^Dialysate 2 volume^ADM||1500||||||F
OBX|125|TX|GuPD000300^Dialysate 3 volume^ADM||1000||||||F
OBX|126|CE|GuPD000401^Prescription verified^ADM||1^At set-up||||||F
OBX|127|CE|GuPD000500^Dialysate 1 type^ADM||1^Dextrose||||||F
OBX|128|CE|GuPD000600^Dialysate 1 concentration^ADM||1^1.5%||||||F
OBX|129|CE|GuPD000700^Dialysate 2 type^ADM||1^Dextrose||||||F
OBX|130|CE|GuPD000800^Dialysate 2 concentration^ADM||1^1.5%||||||F
OBX|131|CE|GuPD000900^Dialysate 3 type^ADM||1^Dextrose||||||F
OBX|132|CE|GuPD001000^Dialysate 3 concentration^ADM||3^2.5%||||||F
OBX|133|CE|GuPD001100^Dialysate last fill type^ADM||1^Dextrose||||||F
OBX|134|CE|GuPD001200^Dialysate last fill concentration^ADM||1^7.5%||||||F
OBX|135|TX|GuPD001300^Dialysate last fill volume^ADM||1000||||||F
OBX|136|TX|GuPD001400^Time continuous cycling peritoneal dialysis initiated^ADM||1000||||||F
OBX|137|TX|GuPD001500^Output, Peritoneal Dialysate Initial Drain Amount^ADM||1000||||||F
OBX|138|TX|GuPD001600^Total ultrafiltration^ADM||1000||||||F
OBX|139|TX|GuPD001700^Dwell average time^ADM||1000||||||F
OBX|140|TX|GuPD001800^Dwell added time^ADM||1000||||||F
OBX|141|TX|GuPD001900^Dwell lost time^ADM||5||||||F
OBX|142|TX|GuPD002000^Dwell comments^ADM||test||||||F
OBX|143|TX|GuPD002200^Number of alarm(s) during therapy^ADM||8||||||F
OBX|144|TX|GuPD002300^Type of alarm(s) during therapy other^ADM||test||||||F
OBX|145|TX|GuPD002400^Alarm(s) comments^ADM||test||||||F
OBX|146|TX|GuPD002500^Intake, Peritoneal Dialysate Last Fill Amount^ADM||1000||||||F
OBX|147|CE|GuPD002600^Type of alarm(s) during therapy^ADM||1^Check drain line||||||F
OBX|148|TX|GuPDCEDO00^Peritoneal dialysis catheter exit site drainage other^ADM||test||||||F
OBX|149|CE|GuPDCESA00^Peritoneal dialysis catheter exit site appearance^ADM||1^Satisfactory||||||F
OBX|150|CE|GuPDCESD00^Peritoneal dialysis catheter exit site drainage^ADM||1^None||||||F
OBX|151|TX|GuPDCESO00^Peritoneal dialysis catheter exit site appearance other^ADM||test||||||F
OBX|152|CE|GuPDCLOC00^Peritoneal dialysis catheter location^ADM||3^Right upper quadrant||||||F
OBX|153|TX|GuPDCMT000^Other peritoneal dialysis comments^ADM||test||||||F
OBX|154|CE|GuPDDCL000^Peritoneal dialysis dialysate clarity^ADM||1^Clear||||||F
OBX|155|TX|GuPDDCLO00^Peritoneal dialysis dialysate clarity other^ADM||test||||||F
OBX|156|TX|GuPDFLS000^Fluid leakage from site^ADM||Y||||||F
OBX|157|TX|GuPDMAD000^Peritoneal dialysis medications added to dialysate^ADM||Y||||||F
OBX|158|TX|GuPDSDIO00^Peritoneal dialysis securement device in use other^ADM||test||||||F
OBX|159|CE|GuPDSDIU01^Peritoneal dialysis securement device in use^ADM||1^Tape||||||F
OBX|160|TX|GuUCB00000^Skin care management^ADM||test||||||F
OBX|161|TX|GuUCB00010^Other gastrointestinal/genitourinary comments^ADM||test||||||F
OBX|162|TX|GuUCINS000^Urinary catheter in situ and patent^ADM||N||||||F
OBX|163|TX|GuUCRCMT00^Urinary catheter removal comments^ADM||test||||||F
OBX|164|TX|GuUCRDT000^Urinary catheter removal date^ADM||20191016||||||F
OBX|165|TX|GuUCRFCO00^Reason for urinary catheter continued use other^ADM||test||||||F
OBX|166|CE|GuUCRFCU00^Reason for urinary catheter continued use^ADM||1^Unrelieved retention||||||F
OBX|167|TX|GuUCSDU000^Urinary catheter securement device in use^ADM||Y||||||F
OBX|168|CE|GuURCLR000^Urine clarity^ADM||1^Clear||||||F
OBX|169|CE|GuURCOL002^Urine colour^ADM||9^Colourless||||||F
OBX|170|TX|GuUROA0000^Urine output adequate^ADM||Y||||||F
OBX|171|CE|GuUROD0000^Urine odour^ADM||1^None||||||F
OBX|172|TX|HX.PSY.RT^Hx Recent Travel^ADM||Y||||||F
OBX|173|CE|HeAXPAR001^Assessment participation^ADM||1^No concerns||||||F
OBX|174|TX|HeAXPARC01^Assessment participation comments^ADM||test||||||F
OBX|175|TX|HeAXPARO01^Assessment participation other^ADM||test||||||F
OBX|176|CE|HeBOLUSP00^Bolus preparation^ADM||1^Within functional limits||||||F
OBX|177|CE|HeBOLUSR00^Bolus retrieval^ADM||1^Within functional limits||||||F
OBX|178|TX|HeCO000200^Verbal communication^ADM||test||||||F
OBX|179|TX|HeSECMGT00^Secretion management comments^ADM||test||||||F
OBX|180|CE|HeSL003300^Oral trials feeding^ADM||1^Full assist||||||F
OBX|181|CE|HeSL003500^Oral trials positioning^ADM||1^Upright in bed||||||F
OBX|182|CE|HeSL004604^Oral residue^ADM||1^Trace/None||||||F
OBX|183|TX|HeSL004800^Pharyngeal phase nasal regurgitation^ADM||Y||||||F
OBX|184|CE|HeSL004902^Pharyngeal phase swallow initiation^ADM||1^No obvious impairment||||||F
OBX|185|CE|HeSL005102^Pharyngeal phase laryngeal excursion^ADM||1^Excursion present||||||F
OBX|186|CE|HeSL005301^Signs consistent with esophageal dysphagia or reflux^ADM||1^Dysphagia w/solids alone||||||F
OBX|187|TX|HeSL005400^Esophageal phase comment^ADM||test||||||F
OBX|188|CE|HeSL005502^Swallowing assessment mealtime behaviours observed^ADM||1^Functional||||||F
OBX|189|TX|HeSL005601^Swallowing assessment mealtime behaviours observed other^ADM||test||||||F
OBX|190|TX|HeSL005701^Swallowing assessment mealtime behaviours observed comments^ADM||test||||||F
OBX|191|CE|HeSL005801^Signs/Symptoms of aspiration observed with^ADM||1^Ice chips||||||F
OBX|192|TX|HeSL006001^Signs/Symptoms of aspiration comments^ADM||test||||||F
OBX|193|CE|HeSL006803^Diet recommendations^ADM||1^NPO||||||F
OBX|194|TX|HeSL006901^Diet recommendations other^ADM||test||||||F
OBX|195|TX|HeSL007001^Plan of care indicates eating at risk^ADM||Y||||||F
OBX|196|TX|HeSL007100^SLP summary oral diet at risk details^ADM||test||||||F
OBX|197|TX|HeSL007200^Ice chips permitted between meals after oral care^ADM||Y||||||F
OBX|198|TX|HeSL007301^Teaspoons of water permitted between meals after oral care^ADM||Y||||||F
OBX|199|CE|HeSL007501^Medication administration form recommendations^ADM||1^Give pills one at a time||||||F
OBX|200|CE|HeSL007601^Medication administration delivery recommendations^ADM||1^Sips of liquid before||||||F
OBX|201|CE|HeSL007800^Dry mouth recommendations^ADM||1^Frequent sips of fluid||||||F
OBX|202|TX|HeSL007900^Dry mouth recommendations other^ADM||test||||||F
OBX|203|CE|HeSL008000^Oral care recommendations for independent patients^ADM||1^Brush teeth twice/day||||||F
OBX|204|TX|HeSL008100^Oral care recommendations for independent patients other^ADM||test||||||F
OBX|205|CE|HeSL008701^Oral care recommendations for dependent patients^ADM||1^Oral care every 4 hours||||||F
OBX|206|TX|HeSL008800^Oral care recommendations for dependent patients other^ADM||test||||||F
OBX|207|CE|HeSL013800^Secretions management^ADM||1^No concerns||||||F
OBX|208|CE|HeSL014001^Voice Motor CN10 quality^ADM||1^Within functional limits~5^Breathy||||||F
OBX|209|TX|HeSL014101^Voice Motor CN10 quality other^ADM||test||||||F
OBX|210|CE|HeSL018600^Bolus control^ADM||1^Within functional limits||||||F
OBX|211|CE|HeSL020202^Oral transfer^ADM||1^Within functional limits||||||F
OBX|212|TX|HeSL023000^Signs/Symptoms of aspiration other^ADM||test||||||F
OBX|213|TX|HeSL023100^Signs consistent with esophageal dysphagia or reflux other^ADM||test||||||F
OBX|214|TX|HeSL034800^Oropharyngeal phases other observations^ADM||est||||||F
OBX|215|TX|HeSL035100^Bolus retrieval other^ADM||test||||||F
OBX|216|TX|HeSL035200^Bolus control other^ADM||test||||||F
OBX|217|TX|HeSL035300^Bolus preparation other^ADM||test||||||F
OBX|218|TX|HeSL036100^Pre-trials suctioning provided^ADM||Y||||||F
OBX|219|TX|HeSL039400^Oral residue other^ADM||test||||||F
OBX|220|TX|HeSL040100^Oral secretions management other^ADM||test||||||F
OBX|221|CE|HeSL041000^Textures/Consistencies dyed blue/green^ADM||1^Ice chips||||||F
OBX|222|TX|HeSL041100^Textures/Consistencies dyed blue/green other^ADM||test||||||F
OBX|223|TX|HeSL041300^Signs/Symptoms of aspiration observed with other^ADM||test||||||F
OBX|224|CE|HeSLP06001^Throat clear strength^ADM||1^Strong||||||F
OBX|225|TX|HeSLP06100^Laryngeal function comment^ADM||test||||||F
OBX|226|TX|HeSLP07001^Sips of water permitted between meals after oral care^ADM||Y||||||F
OBX|227|TX|HeSLP07201^Medication administration form recommendations other^ADM||test||||||F
OBX|228|TX|HeSLP07301^Medication administration delivery recommendations other^ADM||test||||||F
OBX|229|CE|HeSLP09301^Mealtime strategy recommendations^ADM||1^Eat/Feed slowly||||||F
OBX|230|TX|HeSLP09400^Mealtime strategy recommendations other^ADM||test||||||F
OBX|231|CE|HeSLP09500^Compensatory strategy recommendations^ADM||1^Reduced rate of intake||||||F
OBX|232|TX|HeSLP09600^Compensatory strategy recommendations other^ADM||test||||||F
OBX|233|TX|HeSLP09701^Swallow strategy recommendations comments^ADM||test||||||F
OBX|234|TX|HeSLPCOM00^Textures/Consistencies trialled comments^ADM||test||||||F
OBX|235|CE|HeSLPTCT00^Textures/Consistencies trialled^ADM||1^Ice chips||||||F
OBX|236|TX|HeSLPTCT01^Textures/Consistencies trialled other^ADM||test||||||F
OBX|237|TX|HeSLRECC00^Dysphagia recommendations comments^ADM||test||||||F
OBX|238|CE|HeSSASPR00^Signs/Symptoms of aspiration^ADM||1^Cough pre-swallow||||||F
OBX|239|TX|HeSW000700^Eat at risk order in place^ADM||Y||||||F
OBX|240|CE|HeTR000100^Trachea position^ADM||1^Midline||||||F
OBX|241|TX|HeTRCDYS00^Other trach dysphagia assessment comments^ADM||test||||||F
OBX|242|CE|HeVO000100^Voice quality^ADM||1^Within functional limits||||||F
OBX|243|TX|HeVO000200^Voice quality other^ADM||test||||||F
OBX|244|TX|In00000000^Dressing type^ADM||test||||||F
OBX|245|CE|In00000300^Subcutaneous injection: Site^ADM||1^Right upper arm||||||F
OBX|246|CE|In00000400^Subcutaneous injection: Type administered^ADM||1^Analgesic||||||F
OBX|247|TX|In00000500^Subcutaneous injection: Administration reason^ADM||TEST||||||F
OBX|248|TX|In00000600^Skin pre-hospital baseline^ADM||Test||||||F
OBX|249|CE|In00000700^Skin assessment^ADM||1^Skin intact||||||F
OBX|250|TX|In00000800^Specialty mattress^ADM||test||||||F
OBX|251|TX|In00000900^Wound dressing dry and intact^ADM||Y||||||F
OBX|252|CE|In00001000^Skin description^ADM||1^Flaky||||||F
OBX|253|TX|In00001100^Wound dressing change details^ADM||test||||||F
OBX|254|TX|In00001200^Drain dressing present^ADM||Y||||||F
OBX|255|TX|In00001300^Drain dressing changed details^ADM||test||||||F
OBX|256|CE|In00001600^Skin appearance^ADM||1^Redness||||||F
OBX|257|TX|In00001700^Skin appearance other^ADM||test||||||F
OBX|258|TX|InDR000200^Type of dressing applied^ADM||test||||||F
OBX|259|CE|InDRADDE00^Drain drainage description^ADM||1^Serous||||||F
OBX|260|CE|InDRALBD00^Drain location body site^ADM||1^Head||||||F
OBX|261|CE|InDRALBS00^Drain location body site modifier^ADM||1^Right||||||F
OBX|262|TX|InDRASEC00^Drain securement device dry and intact^ADM||Y||||||F
OBX|263|CE|InDRATYE00^Drainage type^ADM||1^Serous||||||F
OBX|264|CE|InDRATYP00^Drain type^ADM||1^Negative pressure device||||||F
OBX|265|TX|InDRCMT000^Other drain comments^ADM||test||||||F
OBX|266|CE|InDREWOU00^Wound cleansing solution^ADM||1^Sterile normal saline||||||F
OBX|267|CE|InEDEMAS00^Edema severity^ADM||1^+1||||||F
OBX|268|TX|InEDEMCM00^Edema comments^ADM||test||||||F
OBX|269|CE|InEDEMLB01^Edema location^ADM||1^Generalized||||||F
OBX|270|CE|InEDEMLM00^Edema location modifier^ADM||3^Right||||||F
OBX|271|CE|InEDEMTP00^Edema type^ADM||1^Pitting||||||F
OBX|272|TX|InINDRES00^Dressing dry and intact^ADM||Y||||||F
OBX|273|CE|InPOSI0001^Immobilization/positioning device type^ADM||1^Cast||||||F
OBX|274|TX|InPOSI0002^Immobilization/positioning device type other^ADM||test||||||F
OBX|275|TX|InPOSI0004^Immobilization/positioning device comments^ADM||est||||||F
OBX|276|CE|InSA001500^Heel pressure relief method^ADM||1^Elevated||||||F
OBX|277|TX|InSA001902^Additional pressure relief methods comments^ADM||test||||||F
OBX|278|TX|InSKCOOT00^Other integumentary comments^ADM||test||||||F
OBX|279|CE|InSKGNTM00^Generalized skin temperature^ADM||1^Hot||||||F
OBX|280|TX|InSKIAPO00^Skin appearance other^ADM||test||||||F
OBX|281|CE|InSKIAPP01^Skin appearance^ADM||1^Normal||||||F
OBX|282|TX|InSKIDEO00^Skin description other^ADM||test||||||F
OBX|283|CE|InSKIMOD01^Skin and wound modifier^ADM||1^Left||||||F
OBX|284|CE|InSKIMOI02^Skin moisture^ADM||1^Dry||||||F
OBX|285|CE|InSKITEM00^Skin temperature^ADM||1^Hot||||||F
OBX|286|CE|InWNDLOC02^Wound location^ADM||9^Back of head||||||F
OBX|287|CE|InWNDMOD00^Wound location modifier^ADM||1^Right||||||F
OBX|288|CE|InWNDTYM00^Wound type^ADM||5^Flap||||||F
OBX|289|CE|InWOULOC02^Skin or wound location^ADM||29^Generalized||||||F
OBX|290|TX|IoNICUIN20^Location^ADM||L arm||||||F
OBX|291|CE|IoSOLUMA00^Solution^ADM||25^Midazolam||||||F
OBX|292|CE|Iv00000300^IV therapy: Type administered^ADM||4^Antibiotic||||||F
OBX|293|TX|Iv00000400^IV therapy: Administration reason^ADM||TEST||||||F
OBX|294|TX|Iv00000500^Other IVT/IM/SC record comments^ADM||TEST||||||F
OBX|295|TX|IvPL000400^Patient's response to procedure^ADM||TEST||||||F
OBX|296|TX|IvRATE0000^Rate^ADM||5.00||||||F
OBX|297|CE|MhAFFECT01^Affect^ADM||1^Appropriate||||||F
OBX|298|TX|MhBEHAVI00^Behaviour other^ADM||test||||||F
OBX|299|TX|MhESAFFE02^Affect other^ADM||test||||||F
OBX|300|TX|MhESMOOD04^Mood^ADM||test||||||F
OBX|301|CE|MhPED00100^Behaviour^ADM||1^Relaxed||||||F
OBX|302|TX|MhTLALPH01^Patient's alternate phone number^ADM||test||||||F
OBX|303|TX|MhTLDISP01^Prescribed medications dispensed^ADM||Y||||||F
OBX|304|TX|MhTLDOPD01^Date of departure^ADM||20191015||||||F
OBX|305|TX|MhTLEDPR01^Expected date of return^ADM||20191015||||||F
OBX|306|TX|MhTLETPR01^Expected time of return^ADM||1000||||||F
OBX|307|TX|MhTLMEDD01^Aware of dosing/time information^ADM||Y||||||F
OBX|308|TX|MhTLPRPH01^Patient's primary phone number^ADM||test||||||F
OBX|309|TX|MhTLRETD01^Date of return^ADM||20191015||||||F
OBX|310|TX|MhTLRETT01^Time of return^ADM||1100||||||F
OBX|311|TX|MhTLSPPH01^Supervising person's primary phone number^ADM||test||||||F
OBX|312|TX|MhTLSUAP01^Supervising person's alternate phone number^ADM||test||||||F
OBX|313|TX|MhTLSUAP02^Supervising person's name and relation to patient^ADM||test||||||F
OBX|314|TX|MhTLTOPD01^Time of departure^ADM||1000||||||F
OBX|315|TX|MhTLUNIT01^Unit phone number provided^ADM||Y||||||F
OBX|316|CE|Mo00000100^Repositioning support provided^ADM||8^Independent||||||F
OBX|317|CE|Mo00000200^Transfer support provided for bed to chair transfer^ADM||8^Independent||||||F
OBX|318|CE|Mo00000300^Transfer support provided for chair to bed transfer^ADM||8^Independent||||||F
OBX|319|CE|Mo00000400^Transfer support provided for toilet transfer^ADM||8^Independent||||||F
OBX|320|CE|Mo00000500^Ambulation support provided^ADM||8^Independent||||||F
OBX|321|CE|Mo00000600^Upper body dressing support provided^ADM||8^Independent||||||F
OBX|322|TX|Mo00000700^Dressing comments^ADM||test||||||F
OBX|323|CE|Mo00000800^Lower body dressing support provided^ADM||8^Independent||||||F
OBX|324|CE|Mo00001200^Dressing support provided (footwear)^ADM||8^Independent||||||F
OBX|325|CE|Mo00001300^Wheelchair propulsion^ADM||8^Independent||||||F
OBX|326|CE|MoAIDAMB01^Ambulation aid^ADM||1^No aid recommended||||||F
OBX|327|CE|MoAIDTRA01^Transfer aid^ADM||2^No aid used||||||F
OBX|328|CE|MoBDASTD00^Mobility in bed assistive devices^ADM||3^Mechanical lift||||||F
OBX|329|CE|MoEQUITR01^Transfer equipment^ADM||2^No equipment used||||||F
OBX|330|TX|MoESP00000^Equipment/Supplies provided^ADM||test||||||F
OBX|331|TX|MoESPR0000^Equipment/Supplies returned^ADM||est||||||F
OBX|332|CE|MoFA000001^Fall prevention strategies^ADM||1^Universal||||||F
OBX|333|TX|MoTRANCO00^Transfer comments^ADM||test||||||F
OBX|334|CE|Ms00000000^Intramuscular injection 1: Site^ADM||4^Left deltoid||||||F
OBX|335|CE|Ms00000100^Intramuscular injection 1: Type administered^ADM||4^Antibiotic||||||F
OBX|336|TX|Ms00000200^Intramuscular injection 1: Administration reason^ADM||TEST||||||F
OBX|337|CE|Ms00000300^Intramuscular injection 2: Site^ADM||1^Right deltoid||||||F
OBX|338|CE|Ms00000400^Intramuscular injection 2: Type administered^ADM||4^Antibiotic||||||F
OBX|339|TX|Ms00000500^Intramuscular injection 2: Administration reason^ADM||TEST||||||F
OBX|340|TX|Ne00005000^Neurological pre-hospital baseline^ADM||test||||||F
OBX|341|CE|Ne00005100^Neurological assessment^ADM||1^Within defined parameters||||||F
OBX|342|TX|Ne00005200^Seizure activity^ADM||Y||||||F
OBX|343|TX|Ne00005300^Seizure precautions in place^ADM||Y||||||F
OBX|344|CE|Ne00005400^Verbal communication^ADM||1^No obvious concerns||||||F
OBX|345|CE|NeGCSEYE03^Glasgow Coma Scale Eye Opening^ADM||4^3- To sound||||||F
OBX|346|CE|NeGCSMOT03^Glasgow Coma Scale Motor Response^ADM||5^5- Localizing||||||F
OBX|347|TX|NeGCSSCR01^GCS score^ADM||13||||||F
OBX|348|CE|NeGCSVER03^Glasgow Coma Scale Verbal Response^ADM||1^5- Oriented||||||F
OBX|349|CE|NeLECONS00^Level of consciousness^ADM||1^Alert||||||F
OBX|350|TX|NeMRARMD00^Arm drift^ADM||Y||||||F
OBX|351|TX|NeMRPAIN01^Response to painful stimuli^ADM||est||||||F
OBX|352|TX|NeNEFI0000^Other neurological findings/complaints^ADM||est||||||F
OBX|353|CE|NeORIENT01^Oriented to^ADM||1^All domains||||||F
OBX|354|CE|NePOSC0000^POSS score^ADM||1^1 - Awake and alert||||||F
OBX|355|CE|NePUEYED01^Eye deviation^ADM||2^Left||||||F
OBX|356|CE|NePURXNL00^Pupil reaction to light^ADM||2^Sluggish||||||F
OBX|357|CE|NePUSHPE00^Pupil shape^ADM||2^Oval||||||F
OBX|358|CE|NePUSIDE00^Pupil side^ADM||2^Right||||||F
OBX|359|TX|NePUSIZE00^Pupil size^ADM||4||||||F
OBX|360|CE|NmARMST100^Arm strength right^ADM||1^Strong||||||F
OBX|361|CE|NmARMST200^Arm strength left^ADM||1^Strong||||||F
OBX|362|CE|NmHNDGR100^Handgrip right^ADM||1^Strong||||||F
OBX|363|CE|NmHNDGR200^Handgrip left^ADM||1^Strong||||||F
OBX|364|CE|NmLEGST100^Leg strength right^ADM||1^Strong||||||F
OBX|365|CE|NmLEGST200^Leg strength left^ADM||1^Strong||||||F
OBX|366|TX|NmSPSKPP00^Skin beneath cervical collar assessed for pressure points^ADM||Y||||||F
OBX|367|TX|NuSLPDR000^Diet restrictions^ADM||test||||||F
OBX|368|CE|OEISO^Infection Control:^ADM||CP^Contact Plus||||||F
OBX|369|CE|Oh00000800^Care plan^ADM||1^Initiated||||||F
OBX|370|TX|OhCO000201^Method of collection^ADM||ATTENDS||||||F
OBX|371|TX|OhDPCB0000^Other deteriorating pt/code blue comments^ADM||test||||||F
OBX|372|TX|OhEDIT0000^Reason for edit^ADM||test||||||F
OBX|373|TX|OhPUPASS00^Purpose of Pass^ADM||test||||||F
OBX|374|CE|OhSPECDL01^Laboratory delivery method^ADM||4^Nurse||||||F
OBX|375|TX|OhSPECRE01^Specimen reason^ADM||DOCTOR'S ORDERS||||||F
OBX|376|TX|OhSPECTP01^Specimen type^ADM||STOOL FOR c-DIFF||||||F
OBX|377|TX|Pa00000000^Pain pre-hospital baseline^ADM||test||||||F
OBX|378|CE|Pa00000100^Pain assessment^ADM||3^Pain present||||||F
OBX|379|TX|PaCOMMEN00^Pain comments^ADM||test||||||F
OBX|380|CE|PaFREQ0000^Pain frequency^ADM||1^At rest||||||F
OBX|381|CE|PaLOCBDS02^Location^ADM||1^Head||||||F
OBX|382|TX|PaNBCATH00^Catheter distal tip intact with removal^ADM||Y||||||F
OBX|383|CE|PaPALOCM00^Pain location modifier^ADM||2^Right||||||F
OBX|384|CE|PaPANVBA00^Pain non-verbal behaviours^ADM||1^Calm||||||F
OBX|385|TX|PaPANVBO00^Pain non-verbal behaviours other^ADM||test||||||F
OBX|386|CE|PaPAQUAL01^Pain quality^ADM||1^Sharp||||||F
OBX|387|TX|PaPARADI00^Pain radiating^ADM||Y||||||F
OBX|388|TX|PaPARADL00^Pain radiating location^ADM||test||||||F
OBX|389|CE|PaPASCL000^Pain scale used^ADM||1^Numeric||||||F
OBX|390|TX|PaPASCRE01^Pain score^ADM||2.00||||||F
OBX|391|TX|PaPATIME00^Time of pain onset^ADM||1000||||||F
OBX|392|TX|PaPATMDE00^Pain timing details^ADM||test||||||F
OBX|393|CE|PaPATYPE00^Pain type of onset^ADM||1^Gradual||||||F
OBX|394|TX|PaPAVRDS00^Pain verbal descriptors scale^ADM||test||||||F
OBX|395|TX|PaPNMGTO00^Pain management techniques other^ADM||test||||||F
OBX|396|CE|PaPNMGTT00^Pain management techniques^ADM||1^Medication||||||F
OBX|397|TX|PaQU000100^Pain quality other^ADM||test||||||F
OBX|398|TX|PaTPSRH000^Pain^ADM||Y||||||F
OBX|399|TX|Ps00000100^Percentage intelligible to unfamiliar listener^ADM||50||||||F
OBX|400|TX|PsPVALOT00^Perceptual voice assessment - loudness other^ADM||test||||||F
OBX|401|CE|PsPVALOU00^Perceptual voice assessment - loudness^ADM||1^Normal||||||F
OBX|402|CE|PsPVALOU01^Loudness^ADM||1^Normal||||||F
OBX|403|CE|PsPVAPIT00^Perceptual voice assessment - pitch^ADM||1^Normal||||||F
OBX|404|CE|PsPVAPIT01^Pitch^ADM||1^Normal~5^Pitch breaks||||||F
OBX|405|TX|PsPVAPOT00^Perceptual voice assessment - pitch other^ADM||yrdy||||||F
OBX|406|CE|PsRESONA00^Speech resonance^ADM||5^Hypernasal||||||F
OBX|407|CE|PsSARTIC00^Articulation^ADM||1^Within functional limits~12^Other||||||F
OBX|408|CE|PsSARTIC03^Articulation^ADM||1^Within functional limits||||||F
OBX|409|TX|PsSARTIO00^Articulation other^ADM||test||||||F
OBX|410|TX|PsSINTCM01^Intelligibility comment^ADM||test||||||F
OBX|411|CE|PsSINTEC00^Intelligibility - conversation^ADM||1^Within functional limits||||||F
OBX|412|CE|PsSINTES00^Intelligibility - sentence^ADM||1^Within functional limits||||||F
OBX|413|CE|PsSINTEW00^Intelligibility - word^ADM||1^Within functional limits||||||F
OBX|414|CE|PsSLP06000^Additional phonation observations^ADM||1^Sudden voice stoppage||||||F
OBX|415|TX|PsSLP06100^Additional phonation observations other^ADM||test||||||F
OBX|416|TX|PsSLPMOS00^Other motor speech comments^ADM||test||||||F
OBX|417|TX|PsSPROOO00^Speech - Prosody Other^ADM||test||||||F
OBX|418|CE|PsSPROSO02^Prosody^ADM||1^Within functional limits||||||F
OBX|419|TX|PsSRESON00^Speech resonance other^ADM||est||||||F
OBX|420|TX|PsSRESPC00^Respiration comment^ADM||test||||||F
OBX|421|CE|PsSRESPI01^Respiration^ADM||1^Within functional limits||||||F
OBX|422|TX|PsSRESPO00^Respiration other^ADM||test||||||F
OBX|423|TX|Re00000000^Respiratory pre-hospital baseline^ADM||test||||||F
OBX|424|CE|Re00000100^Respiratory assessment^ADM||1^Within defined parameters||||||F
OBX|425|TX|ReABNORM00^Abnormal findings comments^ADM||est||||||F
OBX|426|TX|ReAENTRY00^Air entry adequate throughout^ADM||Y||||||F
OBX|427|CE|ReAUAIRE01^Air entry^ADM||3^Absent||||||F
OBX|428|CE|ReAUBTHS02^Breath sounds^ADM||6^Crackles||||||F
OBX|429|CE|ReAULOCT00^Auscultation location^ADM||2^Right lung||||||F
OBX|430|CE|ReAULOMO00^Auscultation location modifier^ADM||1^Anterior||||||F
OBX|431|TX|ReAWS00000^Airway stable^ADM||Y||||||F
OBX|432|TX|ReBCLEAR00^Breath sounds clear throughout^ADM||N||||||F
OBX|433|TX|ReBRESOU00^Breath sounds other^ADM||test||||||F
OBX|434|CE|ReCGDESC01^Cough description^ADM||1^Normal||||||F
OBX|435|TX|ReCGDESO00^Cough description other^ADM||tst||||||F
OBX|436|TX|ReCGPROD00^Cough productive^ADM||Y||||||F
OBX|437|CE|ReCGSTGH00^Cough strength^ADM||1^Strong||||||F
OBX|438|CE|ReCOLMET01^Secretions collection method^ADM||1^Closed/Inline suction||||||F
OBX|439|TX|ReDISTRE00^Respiratory distress comments^ADM||test||||||F
OBX|440|CE|ReDO000100^Digital occlusion reason for trial failure^ADM||1^Patient anxiety||||||F
OBX|441|TX|ReFIND0000^Other respiratory findings^ADM||test||||||F
OBX|442|TX|ReMEDGIV00^Inhalers/Nebulizers given^ADM||Y||||||F
OBX|443|TX|ReOCCCOM00^Digital occlusion comments^ADM||test||||||F
OBX|444|TX|RePEEXPO01^Peak expiratory flow rate (post best of three)^ADM||5||||||F
OBX|445|TX|RePEEXPR01^Peak expiratory flow rate (pre best of three)^ADM||5||||||F
OBX|446|TX|RePEEXRC00^Peak expiratory flow rate comments^ADM||test||||||F
OBX|447|CE|RePHASE000^Phase^ADM||1^Inspiration||||||F
OBX|448|CE|ReRECHEX01^Chest expansion^ADM||1^Symmetrical||||||F
OBX|449|CE|ReREDISI00^Respiratory distress indicators^ADM||1^Accessory muscle use||||||F
OBX|450|TX|ReREDISO00^Respiratory distress indicators other^ADM||test||||||F
OBX|451|CE|ReREDPTH00^Respiratory depth^ADM||1^Normal||||||F
OBX|452|CE|ReRPNM0000^Respiratory pattern^ADM||1^Normal||||||F
OBX|453|CE|ReSCAMNT00^Secretions amount^ADM||1^None||||||F
OBX|454|CE|ReSCCOLR00^Secretions colour^ADM||1^Clear||||||F
OBX|455|CE|ReSCDESC02^Secretions description^ADM||1^Mucoid||||||F
OBX|456|TX|ReSCDESO00^Secretions description other^ADM||test||||||F
OBX|457|CE|ReSE000100^Secretion source^ADM||2^Tracheostomy||||||F
OBX|458|TX|ReSECCOM00^Secretions comments^ADM||test||||||F
OBX|459|TX|ReSECMET00^Secretions collection method other^ADM||test||||||F
OBX|460|CE|ReSECRET00^Secretions source^ADM||1^Suctioned||||||F
OBX|461|TX|ReSPEAKV00^Speaking valve comments^ADM||test||||||F
OBX|462|CE|ReSV000100^Speaking valve reason for trial failure^ADM||1^Patient anxiety~2^Increased RR||||||F
OBX|463|TX|ReTRCORO00^Digital occlusion trial length^ADM||1||||||F
OBX|464|CE|ReTRCUST00^Tracheostomy cuff status^ADM||1^Cuff up||||||F
OBX|465|TX|ReTRSVTL00^Speaking valve trial length^ADM||1||||||F
OBX|466|TX|ReTRTB000^Tracheostomy tube brand^ADM||test||||||F
OBX|467|TX|ReTRTTO00^Tracheostomy tube type other^ADM||test||||||F
OBX|468|CE|ReTRTUSI02^Tracheostomy tube size^ADM||1^4.0 mm||||||F
OBX|469|CE|ReTRTYP00^Tracheostomy type^ADM||1^Cuffed||||||F
OBX|470|CE|ReWRKBRE00^Work of breathing^ADM||1^Normal||||||F
OBX|471|CE|SpIPRATI03^Isolation precautions rationale suspected/confirmed ED^ADM||1^Clostridium difficile||||||F
OBX|472|CE|SpIPRTYP00^Isolation precautions room type^ADM||2^Single occupancy room||||||F
OBX|473|TX|SpOSPATT01^Observed sleep pattern^ADM||test||||||F
OBX|474|TX|SpREPSLE00^Reported sleep pattern^ADM||test||||||F
OBX|475|TX|SpSLEAID00^Sleep aid PRN given^ADM||Y||||||F
OBX|476|TX|SpUPAICM01^Fall prevention comments^ADM||tst||||||F
OBX|477|TX|SpUPINOT01^Fall prevention strategy other^ADM||test||||||F
OBX|478|CE|TR.AIRW^Airway^ADM||1^Adequate||||||F
OBX|479|CE|TR.BR^Breathing^ADM||1^Spontaneous||||||F
OBX|480|TX|TR.CC^History of Chief Complaint^ADM||TWO WEEKS OF COUGHING, FEVER AND CHILLS.||||||F
OBX|481|CE|TR.CIRC2^Appearance^ADM||2^Looks well||||||F
OBX|482|CE|TR.DA^Direct to Care Area^ADM||Yes^Yes||||||F
OBX|483|CE|TR.DIS2^Disability LOC^ADM||1^Baseline for patient||||||F
OBX|484|TX|TePTFMED00^Patient/Family education provided^ADM||Y||||||F
OBX|485|TX|TeSLPCOM00^SLP Dysphagia SMART goals^ADM||test||||||F
OBX|486|TX|VsWT000101^Current Weight^ADM||85.000||||||F
OBX|487|TX|VsWT003500^Goal/target weight^ADM||67.000||||||F
ZFH|LUMED|201908271231|||||

